Efecto del Metodo Dader de Seguimiento Farmacoterapéutico en el riesgo cardiovascular de pacientes con factores de riesgo o enfermedad cardiovascular (EMDADER-CV): Metodos y resultados globales

Amariles, P Faus, MJ Jimenez- Martin, J Sabater Hernandez, D

Garcia-Jimenez, E

Permalink

Closed Access

	Filename	Description	Size
	2013003247OK.pdf		160.9 kB	Adobe PDF	View/Open

Copyright Clearance Process

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Amariles, P	en_US
dc.contributor.author	Faus, MJ	en_US
dc.contributor.author	Jimenez- Martin, J	en_US
dc.contributor.author	Sabater Hernandez, D https://orcid.org/0000-0001-7419-8740	en_US
dc.contributor.author	Garcia-Jimenez, E	en_US
dc.date.issued	2008-01	en_US
dc.identifier.citation	ARS Pharmaceutica, 2008, 49 (Suppl 1), pp. 7 - 24	en_US
dc.identifier.issn	0004-2927	en_US
dc.identifier.uri	http://hdl.handle.net/10453/29021
dc.description.abstract	NA	en_US
dc.language	Spanish	en_US
dc.publisher	Editorial Universidad de Granada	en_US
dc.relation.ispartof	ARS Pharmaceutica	en_US
dc.subject.classification	Pharmacology & Pharmacy	en_US
dc.title	Efecto del Metodo Dader de Seguimiento Farmacoterapéutico en el riesgo cardiovascular de pacientes con factores de riesgo o enfermedad cardiovascular (EMDADER-CV): Metodos y resultados globales	en_US
dc.type	Journal Article
utslib.citation.volume	Suppl 1	en_US
utslib.citation.volume	49	en_US
utslib.for	1115 Pharmacology and Pharmaceutical Sciences	en_US
pubs.embargo.period	Not known	en_US
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Graduate School of Health
utslib.copyright.status	closed_access
pubs.consider-herdc	false	en_US
pubs.issue	Suppl 1	en_US
pubs.volume	49	en_US

Abstract:

NA

Please use this identifier to cite or link to this item: